Interleukin-6 (IL-6) is critical for the lipopolysaccharide (LPS)-induced febrile response. However, the exact source(s) of IL-6 involved in regulating the LPS-elicited fever is still to be identified. One known source of IL-6 is hematopoietic cells, such as monocytes. To clarify the contribution of hematopoietically derived IL-6 to fever, we created chimeric mice expressing IL-6 selectively either in cells of hematopoietic or, conversely, in cells of non-hematopoietic origin. This was performed by extinguishing hematopoietic cells in wild-type (WT) or IL-6 knockout (IL-6 KO) mice by whole-body irradiation and transplanting them with new stem cells. Mice on a WT background but lacking IL-6 in hematopoietic cells displayed normal fever to LPS and were found to have similar levels of IL-6 protein in the cerebrospinal fluid (CSF) and in plasma and of IL-6 mRNA in the brain as WT mice. In contrast, mice on an IL-6 KO background, but with intact IL-6 production in cells of hematopoietic origin, only showed a minor elevation of the body temperature after peripheral LPS injection. While they displayed significantly elevated levels of IL-6 both in plasma and CSF compared with control mice, the increase was modest compared with that seen in LPS injected mice on a WT background, the latter being approximately 20 times larger in magnitude. These results suggest that IL-6 of non-hematopoietic origin is the main source of IL-6 in LPS-induced fever, and that IL-6 produced by hematopoietic cells only plays a minor role.
Introduction
Fever is an adaptive defense that is necessary for the protection and survival of the host in the presence of pathogenic agents (Kluger et al., 1975) . The signaling pathways regulating fever are complex and still remain unclear. It is however generally accepted that prostaglandin E 2 (PGE 2 ), acting on prostaglandin E receptor type 3 (EP 3 ) expressing neurons in the preoptic area of the hypothalamus, is the principal mediator of fever (Engblom et al., 2003; Lazarus et al., 2007) . In experimental animals, lipopolysaccharide (LPS), a component of the cell wall envelope of Gram-negative bacteria, is commonly used to provoke a febrile response (Oka et al., 2003; Romanovsky et al., 1998; Rudaya et al., 2005) . A large part of the LPS-elicited production of PGE 2 and concomitant fever response is thought to involve cytokines, such as interleukin-6 (IL-6) and interleukin-1b (IL-1b) (Conti et al., 2004; Nadjar et al., 2005; Rummel et al., 2011) .
IL-6 is a critical proinflammatory cytokine for the febrile response, because neither IL-6 knock-out (IL-6 KO) mice, nor animals treated with IL-6 antiserum develop fever upon peripheral immune stimulation (Cartmell et al., 2000; Chai et al., 1996; Kozak et al., 1998) . However, depending on species, IL-6 per se has been reported to induce no or only weak to moderate fever (Blatteis, 1990; Cartmell et al., 2000; Dinarello et al., 1991; Harre et al., 2002; Nilsberth et al., 2009a; Rummel et al., 2006; Sakata et al., 1991; Wang et al., 1997) . Several explanations for these contradictory observations have been proposed. For example, it has been suggested that IL-6 needs to reach a threshold level to activate the transcription factor STAT3 and initiate fever (Rummel et al., 2004) . Another hypothesis is that IL-6 and IL-1b act in a synergistic way, based on the finding that IL-6 induces fever if administered together with a subfebrile dose of IL-1b (Cartmell et al., 2000; Harden et al., 2008) . Thus, although the presence of IL-6 has been shown to be necessary for fever, its role in the regulation of the febrile response is not clear.
IL-6 is a pleiotropic cytokine with widespread expression. IL-6 is synthesized and secreted by monocytes/macrophages (Bauer et al., 1988; Callery et al., 1992; May et al., 1988; Northoff et al., 1987) , fibroblasts (Helfgott et al., 1987; May et al., 1988) , brain endothelial cells (Kakumu et al., 1992; Reyes et al., 1999; Verma et al., 2006) , muscle cells (Andreasen et al., 2011) , and hepatocytes (Panesar et al., 1999; Saad et al., 1995) following challenge with bacterial endotoxin. IL-6 has also been shown to be produced by
